Pfizer stock after-hours at EUR 25.04: minus 0.67 percent
Published on 10/01/2026 at 21:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer stock was at EUR 25.04 after-hours at 9:11 p.m. CEST on October 1, 2026, down 0.67 percent versus the prior close of EUR 25.21 at Lang & Schwarz.
Pfizer stock after the Xetra close
The euro price was EUR 0.17 below the previous Lang & Schwarz close. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Pfizer stock.
Phase 2 study meets primary endpoint
Pfizer Inc. reported detailed results from an ongoing Phase 2 study of investigational tilrekimig in adults with moderate-to-severe atopic dermatitis. The study met its primary endpoint, with a statistically significant increase versus placebo in the share of participants achieving EASI-75 at Week 16. EASI-75 represents at least a 75 percent reduction in the Eczema Area and Severity Index.
The company said 62.5 percent of patients receiving 450 milligrams every two weeks achieved EASI-75, compared with 19.9 percent on placebo. In the monthly-dose groups, response rates were 58.5 percent, 61.0 percent and 47.8 percent for 400 milligrams, 200 milligrams and 50 milligrams, respectively, versus 9.1 percent for placebo. Pfizer said the Phase 3 program is underway in atopic dermatitis and asthma, while a Phase 2b/3 study is ongoing in chronic obstructive pulmonary disease.
